Overview
Paul Kim is a Hematologist Oncology specialist and an Oncologist in Fletcher, North Carolina. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Anemia. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Myelodysplastic Syndrome (MDS), and Acute Mountain Sickness. Dr. Kim is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ifeyinwa Osunkwo is a Pediatrics specialist and a Hematologist in Shelby, North Carolina. Dr. Osunkwo is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.
Anderson Oncology-Hematology Clinic PA
Jeffrey Delo is a Hematologist Oncology specialist and a Hematologist in Anderson, South Carolina. Dr. Delo is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Anemia, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Delo is currently accepting new patients.
Henderson County Hospital Corporation
John Hill is a Hematologist Oncology specialist and a Hematologist in Hendersonville, North Carolina. Dr. Hill is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Large-Cell Immunoblastic Lymphoma. Dr. Hill is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Mountain SicknessDr. Kim isAdvanced. Learn about Acute Mountain Sickness.
- Childhood Iron Deficiency Anemia
- Familial Prostate CancerDr. Kim isAdvanced. Learn about Familial Prostate Cancer.
- Iron Deficiency AnemiaDr. Kim isAdvanced. Learn about Iron Deficiency Anemia.
- Myelodysplastic Syndrome (MDS)
- Prostate CancerDr. Kim isAdvanced. Learn about Prostate Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Kim isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Kim isExperienced. Learn about Adult T-Cell Leukemia.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Kim isExperienced. Learn about Anal Cancer.
- AnemiaDr. Kim isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Kim isExperienced. Learn about Antiphospholipid Syndrome.